AMGN NASDAQ Week ended 24 Jul 2026

Weekly Investor Report

Amgen Inc · Healthcare · Drug Manufacturers - General

Open interactive chart View report data Download investor PDF
Latest close 376.0 USD
2.7% latest week
Weekly setup

Constructive, but selective

The weekly trend is active. Price is 7.5% above the Trend Line and sits at 90.1% of its 52-week range. The latest completed week returned 2.7%, after a 4.9% four-week move. The latest factor snapshot indicates quality ranks strongly versus its universe; growth is moderate; valuation is expensive relative to peers. Options positioning is mixed with 39/100 conviction, while the latest news-sentiment score is 55/100. Near-term considerations: price is close to its 52-week high; volume confirmation is below normal; earnings are due in 6d.

Setup score 64 out of 100
Latest Close 376.0 USD 24 Jul 2026
1W Return 2.7% latest completed week
4W Return 4.9% short-term follow-through
12W Return 14.9% quarterly tape
Trend Breadth 69.2% 36 of 52 weeks active
Volume Ratio 0.9x vs 13-week average
What is working
  • The trend backdrop is active with a 5-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • 2 reversal markers appear in the recent smart-money tape.
What to watch next
  • Price is close to its 52-week high; watch for continuation or exhaustion.
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 2.7% Latest completed week; four-week move 4.9%. Indicator stack 55/86 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Options pressure Mixed 39/100 conviction; expected move 4.2%. News sentiment 55/100 34 relevant articles in the latest sentiment read. Event risk 6d Next report is scheduled for 04 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 7.5% above the Trend Line and sits at 90.1% of its 52-week range. The latest completed week returned 2.7%, after a 4.9% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.9x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
30 Jan 6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.6312-week average 0.47

12-week confirmation

Trend active5/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure4/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership3/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.63Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers22 reversal markers

No recent accumulation markers. 2 reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 4.9% over four weeks, 14.9% over 12 weeks, and 26.3% over one year. The current trend has remained active for 5 consecutive weeks.

Performance by holding period

1W2.7%
4W4.9%
12W14.9%
26W10.7%
52W26.3%
Active trend streak5 weeks
Active weeks in one year36
Trend breadth69.2%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.43Latest activity-pressure read.
Pressure change359.2%Four-week change in activity pressure.
Leadership5.08Latest relative-leadership reading.
RS change272.1%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks strongly versus its universe; growth is moderate; valuation is expensive relative to peers.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Dec 2025 Field coverage 97% Model confidence 93%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength52/100Blend of value, momentum, and quality. Underlying universe rank 49; rank 1 is best.
Value14/100Relative valuation strength. Underlying universe rank 87; rank 1 is best.
Quality99/100Profitability and accounting quality. Underlying universe rank 2; rank 1 is best.
Momentum73/100Medium-term price momentum. Underlying universe rank 28; rank 1 is best.
Growth36/100Revenue and earnings growth. Underlying universe rank 65; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
26.0x
Price divided by trailing earnings.
Price / sales
5.5x
Market value relative to trailing revenue.
EV / EBITDA
14.9x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
5.2%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
71.5%
Gross profit retained from each unit of revenue.
Operating margin
31.7%
Operating profit retained from revenue.
Free-cash-flow margin
34.7%
Free cash flow generated from revenue.
Return on invested capital
18.6%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
9.1%
Latest one-year revenue growth.
EPS growth
31.5%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-4.1%
Latest one-year free-cash-flow growth.
Piotroski F-score
7/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
2.6%
Cash dividends relative to market value.
Buyback yield
0.0%
Net share repurchases relative to market value.
Shareholder yield
2.6%
Dividend yield plus net buyback yield.
Net debt / EBITDA
2.7x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningMixed

AMGN shows mixed options pressure with a 39/100 conviction score, put-call volume ratio of 0.97, expected move of 4.2%, and Sharemaestro trend signal active.

Conviction39/100
Expected move4.2%
Put/call volume0.97
Pressure4
Speculation42
Volatility52
Trend agreement89
Open options detail
Insider activity11 / 9

11 acquisitions and 9 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment55/100

Weighted news tone is neutral across 34 relevant articles.

10 positive · 23 neutral · 1 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings6dNext report is scheduled for 04 Aug 2026; event risk rises as the date approaches.
Options expected move4.2%Nearest-chain priced movement where available.
52-week drawdown-3.2%Distance below the 52-week high.
13-week volatility3.3%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher14 of 2612 weeks finished lower.
Best week+12.4%Week of 6 Feb.
Worst week-5.0%Week of 20 Mar.
Latest week+2.7%Week of 24 Jul.

Shape of recent returns

Strong gains3
Modest gains11
Flat weeks0
Modest losses8
Sharp losses4
Recent vol3.3%13-week weekly-return volatility.
Base vol3.7%52-week weekly-return volatility.
Up/down split27/25Count of positive and negative weeks in the 52-week window.
Average skew3.4% / -2.5%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape63/100

Trend, activity pressure, participation, and risk combine to a 63/100 tape read.

 Indicator analysis38/100

Latest 12-week confirmation: trend 5/12, activity pressure 4/12, relative leadership 3/12.

Activity pressure 0.63; 2 reversal markers Factors59/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 54 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options58/100

AMGN shows mixed options pressure with a 39/100 conviction score, put-call volume ratio of 0.97, expected move of 4.2%, and Sharemaestro trend signal active.

Mixed · Options-market disagreement · Expected move 4.2% Sentiment55/100

Weighted news tone is neutral across 34 relevant articles.

Amgen Stock Erased a 17% Drawdown. A MariTide Switch Study Explains Why. Insiders11 / 9

11 acquisitions and 9 disposals in the latest 180-day insider tape.

 Earnings6d

Next report is scheduled for 04 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
24 Jul 2026376.0 USD2.7%349.9 USD292.9 USD0.435.0811.8MOn
17 Jul 2026366.3 USD0.8%348.3 USD291.8 USD0.350.8011.0MOn
10 Jul 2026363.4 USD-2.9%346.9 USD290.9 USD0.17-4.109.9MOn
3 Jul 2026374.1 USD4.4%345.2 USD289.9 USD0.140.469.4MOn
26 Jun 2026358.3 USD6.1%343.6 USD288.7 USD-0.17-2.9513.2MOn
19 Jun 2026337.6 USD-5.0%343.0 USD287.7 USD-0.55-12.6319.5MOff
12 Jun 2026355.2 USD1.6%342.8 USD286.9 USD-0.73-5.9016.3MOff
5 Jun 2026349.6 USD3.8%342.0 USD286.0 USD-1.05-5.4312.3MOff
29 May 2026336.8 USD-0.7%340.7 USD285.0 USD-1.10-13.128.9MOff
22 May 2026339.3 USD4.0%339.3 USD284.1 USD-1.06-10.2112.5MOff
15 May 2026326.3 USD-0.9%337.5 USD283.2 USD-1.07-12.7512.7MOff
8 May 2026329.2 USD0.6%336.3 USD282.4 USD-0.91-12.4315.4MOff
1 May 2026327.3 USD-4.3%334.8 USD281.7 USD-0.80-8.3515.0MOn
24 Apr 2026341.9 USD-3.0%333.6 USD280.9 USD-0.73-3.0210.5MOn
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.